Microtomes operate on different technologies, including manual, semi-automated, and fully automated. Manual microtomes segment accounted for the largest market share in 2018. Manual microtomes are cost-effective and are easier to use as compared to automatic and semi-automatic modules. These factors are supporting their adoption in the market, and the trend is anticipated to continue over the forecast period.
The report Microtome Market is
expected to grow from USD 129 million in 2019 to reach USD 177 million by 2024,
at a CAGR of 6.5%.
Download PDF Brochure:
- https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=230495411
Clinical laboratories and hospital
laboratories are the main end-users of microtomes, among others. In 2018, the
hospital laboratories segment accounted for the largest market share and was
expected to grow at the highest CAGR during the forecast period. The large
share of the hospital laboratories segment is attributed to the increasing
number of patient visits to hospitals, rising number of in-house clinical
diagnostic procedures performed in hospitals, growing awareness regarding early
diagnosis, and the availability of reimbursements in developed markets for
clinical tests performed in hospitals.
By region, the microtomes market is
segmented into North America, Europe, Asia Pacific, and the Rest of the World
(RoW). In 2018, North America accounted for the largest market share, followed
by Europe.
Speak To Analyst: - https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=230495411
The prominent players operating in the
microtomes market include Thermo Fisher Scientific (US), Danaher Corporation
(US), Sakura Finetek (Japan), SLEE Medical GmbH (Germany), MEDITE GmbH
(Germany), Histo-Line Laboratories (Italy), Amos Scientific (Australia), RMC
Boeckeler (US), Diapath S.p.A. (Italy), and Jinhua YIDI Medical Appliance
(China).
No comments:
Post a Comment